Assessment of the percentage of full recombinant adeno-associated virus particles in a gene therapy drug using CryoTEM | Zendy

Mathieu ColombDelsuc | Zendy; Roman Raim | Zendy; Christian Fiedler | Zendy; Stefan Reuberger | Zendy; Johannes Lengler | Zendy; Rickard Nordström | Zendy; Martin Ryner | Zendy; I. Mihaela Folea | Zendy; Barbara Kraus | Zendy; Juan A. Hernández Bort | Zendy; IdaMaria Sintorn | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Assessment of the percentage of full recombinant adeno-associated virus particles in a gene therapy drug using CryoTEM

Author(s) -

Mathieu ColombDelsuc,

Roman Raim,

Christian Fiedler,

Stefan Reuberger,

Johannes Lengler,

Rickard Nordström,

Martin Ryner,

I. Mihaela Folea,

Barbara Kraus,

Juan A. Hernández Bort,

IdaMaria Sintorn

Publication year - 2022

Publication title -

plos one

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.99

H-Index - 332

ISSN - 1932-6203

DOI - 10.1371/journal.pone.0269139

Subject(s) - recombinant dna , computational biology , genetic enhancement , immunogenicity , reliability (semiconductor) , adeno associated virus , viral vector , materials science , drug , biomedical engineering , vector (molecular biology) , computer science , virology , biological system , medicine , biology , gene , physics , pharmacology , genetics , immunology , power (physics) , immune system , quantum mechanics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research